샘플 요청 목록

 카트 문의
시장보고서
상품코드
1756396

세계의 렌티바이러스 벡터 시장 : 제품 종류별, 치료 분야별, 제조 규모별, 워크플로우 단계별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Lentiviral Vectors Market, By Product Type, By Therapeutic Area, By Manufacturing Scale, By Workflow Stage, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 298 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

렌티바이러스 벡터의 시장 규모는 2024년에 1억 7,010만 달러로 2025년부터 2032년까지 11.92%의 CAGR로 확대될 전망입니다.

렌티바이러스 벡터 시장 역학

유전자 도입 시스템의 발전으로 렌티바이러스 벡터의 채택 가속화

유전자 도입 시스템의 발전으로 렌티바이러스 벡터는 전 세계적으로 치료 및 연구 분야에서 렌티바이러스 벡터의 채택이 가속화되고 있습니다. 미국 국립암연구소(NCI)의 보고에 따르면 렌티바이러스 벡터는 CAR-T 세포 치료의 핵심이며, FDA가 승인한 일부 치료법은 표적 암 치료를 위해 환자의 면역세포를 변형시키기 위해 렌티바이러스 벡터를 활용하고 있습니다. 또한, 미국 국립보건원(NIH)은 렌티바이러스 벡터의 안전성과 확장성을 개선하고 삽입형 돌연변이 유발에 대한 우려를 해결하기 위해 여러 프로그램에 자금을 지원하고 있습니다. 유럽에서는 EMA와 같은 규제 기관이 렌티바이러스를 이용한 유전자 치료의 임상시험 승인을 촉진하고 있으며, 이는 렌티바이러스의 가능성에 대한 신뢰가 높아졌음을 반영합니다. 이러한 노력은 유전자 도입 기술의 강화가 맞춤형 의료의 범위를 확장하고 유전성 및 후천성 질환에 대한 치료 옵션을 발전시키는 데 있어 중요한 역할을 할 것임을 강조하고 있습니다.

렌티바이러스 벡터 시장 : 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2025-2032년) 동안 약 11.92%의 CAGR로 매년 성장할 것으로 추정됩니다.

제품 유형별로는 렌티바이러스 포장 시스템이 2024년 가장 큰 시장 점유율을 차지할 것으로 예측됐습니다.

치료 분야별로는 암이 2024년 주요 치료 영역으로 꼽혔습니다.

제조 규모별로는 2024년 임상 등급이 주요 제조 규모에 해당합니다.

워크플로우 단계별로는 2024년 바이러스 패키징이 선두를 달리고 있습니다.

용도별로는 세포 치료제(CAR-T 등)가 2024년 주요 용도였습니다.

지역별로는 북미가 2024년 주요 수익원이었습니다.

렌티바이러스 벡터 시장 : 세분화 분석

렌티바이러스 벡터 세계 시장은 제품 유형, 치료 영역, 제조 규모, 워크플로우 단계, 용도, 지역에 따라 세분화됩니다.

시장은 제품 유형에 따라 6가지 카테고리로 나뉩니다. 렌티바이러스 패키징 시스템, 렌티바이러스 플라스미드, 맞춤형 렌티바이러스 생산 서비스, 즉시 사용 가능한 렌티바이러스, 렌티바이러스 프로모터, 렌티바이러스 퓨전 태그입니다. 렌티바이러스 패키징 시스템은 벡터 어셈블리에서의 역할로 인해 우위를 점하고 있습니다. 렌티바이러스 플라스미드는 유전자 복제에 필수적입니다.

시장은 치료 영역에 따라 4가지 카테고리로 나뉩니다. 암, 희귀질환, 감염질환, 신경질환입니다. 희귀질환은 맞춤 유전자 치료의 혜택을 받을 수 있으며, 신경질환은 유전자 편집과 벡터 전달 연구가 진행되고 있는 새로운 타겟입니다.

렌티바이러스 벡터 시장 : 지역별 분석

렌티바이러스 벡터 시장은 지역별로 큰 차이를 보이고 있으며, 북미는 잘 구축된 바이오의약품 인프라, 유전자 치료 연구에 대한 활발한 자금 지원, FDA를 중심으로 한 규제 환경의 지원으로 시장을 선도하고 있습니다. 미국에서는 특히 CAR-T 세포 치료제 및 희귀 유전성 질환에서 렌티바이러스 벡터를 이용한 임상시험이 많이 진행되고 있습니다. 독일, 영국, 프랑스 등의 국가들이 유전자 치료 기술 혁신에 많은 투자를 하고 있으며, 유럽의약품청의 간소화된 규제 경로의 혜택을 누리고 있습니다. 아시아태평양은 중국, 일본, 한국 등의 국가에서 바이오테크놀러지와 세포 치료 프로그램 추진을 위한 정부의 노력이 활발해짐에 따라 빠르게 부상하고 있습니다. 이들 국가에서는 학계와 바이오텍 기업과의 공동 개발이 활발해지면서 렌티바이러스 벡터를 이용한 치료법의 임상 개발 및 상용화가 가속화되고 있습니다. 한편, 라틴아메리카와 중동은 지역 유전성 질환 대응과 의료 접근성 개선에 초점을 맞추고 파트너십과 인프라 개발을 통해 점차 역량을 확대하고 있습니다.

렌티바이러스 벡터 시장 : 경쟁 상황

렌티큘러 바이러스 벡터 시장의 경쟁 구도는 기존 생명공학 기업, 신생 벤처기업, 유전자 도입 기술 발전에 주력하는 학술 연구기관의 조합으로 형성되고 있습니다. 주요 기업들은 유전자 도입 효율을 높이고 삽입 돌연변이 유발 위험을 줄이기 위해 보다 안전하고 효율적인 렌티바이러스 벡터 플랫폼 개발에 투자하고 있습니다. 바이오제약기업과 학술센터와의 전략적 제휴 및 라이선싱 계약이 일반화되어 빠른 기술 혁신과 임상 적용이 가능해졌습니다. 기업들은 또한 임상용 렌티바이러스 벡터에 대한 수요 증가에 대응하기 위해 생산능력을 확장하고, 확장성과 규제 준수에 중점을 두고 있습니다. 또한, 자가 불활성화 벡터, 표적 전달 시스템 등 치료 효과를 높이기 위한 새로운 벡터 엔지니어링 기술 개발 노력으로 경쟁이 심화되고 있습니다. 지적재산권 관리와 독점적 기술 권리 확보는 진화하는 이 분야에서 시장 지위를 유지하고 장기적인 성장을 촉진하기 위해 계속 중요하게 작용할 것입니다.

목차

제1장 렌티바이러스 벡터 시장 개요

  • 분석 범위
  • 시장 추정 기간

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 렌티바이러스 벡터의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 렌티바이러스 벡터 시장 : 산업 분석

  • PEST 분석
  • Porter's Five Forces 분석
  • 시장 성장 전망 : 매핑
  • 규제 체제 분석

제5장 렌티바이러스 벡터 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아·우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 렌티바이러스 벡터 시장 상황

  • 렌티바이러스 벡터 시장 점유율 분석(2024년)
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 렌티바이러스 벡터 시장 : 제품 종류별

  • 개요
    • 부문별 점유율 분석 : 제품 종류별
    • 렌티바이러스 패키징 시스템
    • 렌티바이러스 플라스미드
    • 커스텀 렌티바이러스 생산 서비스
    • Ready-to-use 렌티바이러스
    • 렌티바이러스 프로모터
    • 렌티바이러스 융합 태그

제8장 렌티바이러스 벡터 시장 : 치료 분야별

  • 개요
    • 부문별 점유율 분석 : 치료 분야별
    • 암
    • 희귀질환
    • 감염증
    • 신경질환

제9장 렌티바이러스 벡터 시장 : 제조 규모별

  • 개요
    • 부문별 점유율 분석 : 제조 규모별
    • 연구 등급
    • 임상 등급
    • 실용 등급

제10장 렌티바이러스 벡터 시장 : 워크플로우 단계별

  • 개요
    • 부문별 점유율 분석 : 워크플로우 단계별
    • 플라스미드 구축
    • 바이러스 패키징
    • 정제·농축
    • QC·분석
    • 업스트림 처리
    • 다운스트림 처리

제11장 렌티바이러스 벡터 시장 : 용도별

  • 개요
    • 부문별 점유율 분석 : 용도별
    • 유전자 치료
    • 세포 치료(예 : CAR-T)
    • 백신 개발
    • 기능유전체학

제12장 렌티바이러스 벡터 시장 : 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 스웨덴
    • 러시아
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 인도네시아
    • 태국
    • 필리핀
    • 기타
  • 라틴아메리카(LATAM)
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 튀르키예
    • 알제리
    • 이집트
    • 기타

제13장 주요 벤더 분석 : 렌티바이러스 벡터 업계

  • 경쟁 대시보드
    • 경쟁 벤치마크
    • 경쟁 포지셔닝
  • 기업 개요
    • Aldevron
    • Bio-Techne
    • Cell and Gene Therapy Catapult
    • Charles River Laboratories
    • Creative Biogene
    • ExcellGene SA
    • GeneCopoeia
    • Merck KGaA
    • OriGene Technologies
    • Oxford Biomedica
    • Sartorius AG
    • SIRION Biotech
    • Thermo Fisher Scientific
    • VectorBuilder
    • Vigene Biosciences
    • Wuxi Advanced Therapies
    • Others

제14장 AnalystView의 전방위적 분석

ksm 25.07.03

REPORT HIGHLIGHT

Lentiviral Vectors Market size was valued at US$ 170.10 Million in 2024, expanding at a CAGR of 11.92% from 2025 to 2032.

The Lentiviral Vectors Market involves the development and use of lentivirus-based delivery systems primarily for gene therapy, vaccine development, and research applications. Increasing demand for effective gene delivery methods in treating genetic disorders and cancers has expanded the use of lentiviral vectors, which are favored for their ability to integrate into host genomes and provide stable, long-term gene expression. In 2023, over 60% of gene therapy clinical trials incorporated lentiviral vectors to enhance therapeutic outcomes. However, challenges like high manufacturing costs, biosafety concerns, and potential insertional mutagenesis limit widespread adoption. Advances in vector engineering and scalable production methods offer promising opportunities to improve safety profiles and reduce costs. Additionally, growing investments in CAR-T cell therapies and immunotherapy research present significant avenues for market expansion as lentiviral vectors play a crucial role in modifying immune cells for targeted treatments.

Lentiviral Vectors Market- Market Dynamics

Advancements in gene delivery systems to accelerate lentiviral vector adoption

Advancements in gene delivery systems are accelerating the adoption of lentiviral vectors in therapeutic and research applications worldwide. The National Cancer Institute (NCI) reports that lentiviral vectors have become a cornerstone in CAR-T cell therapies, with several FDA-approved treatments utilizing these vectors to modify patients' immune cells for targeted cancer treatment. Additionally, the U.S. National Institutes of Health (NIH) has funded multiple programs aimed at improving lentiviral vector safety and scalability, addressing concerns related to insertional mutagenesis. In Europe, regulatory agencies such as the EMA have facilitated clinical trial approvals for lentiviral-based gene therapies, reflecting growing confidence in their potential. These efforts underscore the critical role of enhanced gene delivery technologies in expanding the reach of personalized medicine and advancing treatment options for genetic and acquired diseases.

Lentiviral Vectors Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.92% over the forecast period (2025-2032)

Based on product type segmentation, Lentiviral Packaging Systems was predicted to show maximum market share in the year 2024

Based on Therapeutic Area segmentation, Cancer was the leading Therapeutic Area in 2024

Based on Manufacturing Scale segmentation, Clinical Grade was the leading Manufacturing Scale in 2024

Based on Workflow Stage segmentation, Viral Packaging was the leading Workflow Stage in 2024

Based on Application segmentation, Cell Therapy (e.g., CAR-T) was the leading Application in 2024

On the basis of region, North America was the leading revenue generator in 2024

Lentiviral Vectors Market- Segmentation Analysis:

The Global Lentiviral Vectors Market is segmented on the basis of Product Type, Therapeutic Area, Manufacturing Scale, Workflow Stage, Application, and Region.

The market is divided into six categories based on product type: Lentiviral Packaging Systems, Lentiviral Plasmids, Custom Lentivirus Production Services, Ready-to-use Lentivirus, Lentiviral Promoter, and Lentiviral Fusion Tags. Lentiviral Packaging Systems dominate due to their role in vector assembly; Lentiviral Plasmids are essential for gene cloning; Custom Lentivirus Production Services offer tailored solutions; Ready-to-use Lentivirus provides convenience; Lentiviral Promoters and Fusion Tags support gene expression and protein tracking.

The market is divided into four categories based on Therapeutic Area: Cancer, Rare Diseases, Infectious Diseases, and Neurological Disorders. Cancer leads as the primary therapeutic area due to extensive CAR-T applications; Rare Diseases benefit from personalized gene therapies; Infectious Diseases see growing vector use for vaccine development; Neurological Disorders are emerging targets with increasing research in gene editing and vector delivery.

Lentiviral Vectors Market- Geographical Insights

The Lentiviral Vectors Market shows significant regional variation, with North America leading due to its well-established biopharmaceutical infrastructure, robust funding for gene therapy research, and supportive regulatory environment led by the FDA. The U.S. hosts numerous clinical trials utilizing lentiviral vectors, particularly in CAR-T cell therapies and rare genetic disorders. Europe is also a key player, with countries like Germany, the UK, and France investing heavily in gene therapy innovation and benefiting from the European Medicines Agency's streamlined regulatory pathways. The Asia-Pacific region is rapidly emerging, driven by increased government initiatives in China, Japan, and South Korea to advance biotechnology and cell therapy programs. Growing collaborations between academic institutions and biotech firms in these countries are accelerating clinical development and commercialization of lentiviral vector-based therapies. Meanwhile, Latin America and the Middle East are gradually expanding their capabilities through partnerships and infrastructure development, focusing on addressing regional genetic disorders and improving healthcare access.

Lentiviral Vectors Market- Competitive Landscape:

The competitive landscape of the Lentiviral Vectors Market is shaped by a combination of established biotechnology companies, emerging startups, and academic research institutions focused on advancing gene delivery technologies. Leading players are investing in the development of safer, more efficient lentiviral vector platforms to improve transduction efficiency and reduce insertional mutagenesis risks. Strategic collaborations and licensing agreements between biopharma companies and academic centers are common, enabling rapid innovation and clinical translation. Companies are also expanding manufacturing capabilities to meet growing demand for clinical-grade lentiviral vectors, emphasizing scalability and regulatory compliance. Additionally, competition is intensified by efforts to develop novel vector engineering techniques, such as self-inactivating vectors and targeted delivery systems, to enhance therapeutic efficacy. Intellectual property management and securing exclusive rights to proprietary technologies remain critical for maintaining market position and fostering long-term growth in this evolving sector.

Recent Developments:

In June 2024, Charles River Laboratories announced a strategic collaboration with the Gates Institute at University of Colorado Anschutz to manufacture lentiviral vectors, accelerating CAR-T cell therapy development for hematological cancers and enhancing advanced cell and gene therapy manufacturing capabilities.

In September 2024, Rentschler Biopharma launched lentiviral vector manufacturing services at its Stevenage, UK facility, introducing a new LVV toolbox to complement existing AAV vector offerings and accelerate advanced therapy development for gene and cell therapy applications, including rare diseases and cancer immunotherapy.

In April 2025, ViroCell Biologics manufactured a GMP lentiviral vector for UCL's clinical trial, accelerating innovative CAR T-cell therapy development for relapsed paediatric acute lymphoblastic leukaemia, with the first patient enrolled in March 2025, aiming to prevent relapse in childhood blood cancer.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LENTIVIRAL VECTORS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Aldevron
  • Bio-Techne
  • Cell and Gene Therapy Catapult
  • Charles River Laboratories
  • Creative Biogene
  • ExcellGene SA
  • GeneCopoeia
  • Merck KGaA
  • OriGene Technologies
  • Oxford Biomedica
  • Sartorius AG
  • SIRION Biotech
  • Thermo Fisher Scientific
  • VectorBuilder
  • Vigene Biosciences
  • Wuxi Advanced Therapies
  • Others

GLOBAL LENTIVIRAL VECTORS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Lentiviral Packaging Systems
  • Lentiviral Plasmids
  • Custom Lentivirus Production Services
  • Ready-to-use Lentivirus
  • Lentiviral Promoter
  • Lentiviral Fusion Tags

GLOBAL LENTIVIRAL VECTORS MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

  • Cancer
  • Rare Diseases
  • Infectious Diseases
  • Neurological Disorders

GLOBAL LENTIVIRAL VECTORS MARKET, BY MANUFACTURING SCALE- MARKET ANALYSIS, 2019 - 2032

  • Research Grade
  • Clinical Grade
  • Commercial Grade

GLOBAL LENTIVIRAL VECTORS MARKET, BY WORKFLOW STAGE- MARKET ANALYSIS, 2019 - 2032

  • Plasmid Construction
  • Viral Packaging
  • Purification & Concentration
  • QC & Analytics
  • Upstream Processing
  • Downstream Processing

GLOBAL LENTIVIRAL VECTORS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Gene Therapy
  • Cell Therapy (e.g., CAR-T)
  • Vaccine Development
  • Functional Genomics

GLOBAL LENTIVIRAL VECTORS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Lentiviral Vectors Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Lentiviral Vectors Market Snippet by Product Type
    • 2.1.2. Lentiviral Vectors Market Snippet by Therapeutic Area
    • 2.1.3. Lentiviral Vectors Market Snippet by Manufacturing Scale
    • 2.1.4. Lentiviral Vectors Market Snippet by Workflow Stage
    • 2.1.5. Lentiviral Vectors Market Snippet by Application
    • 2.1.6. Lentiviral Vectors Market Snippet by Country
    • 2.1.7. Lentiviral Vectors Market Snippet by Region
  • 2.2. Competitive Insights

3. Lentiviral Vectors Key Market Trends

  • 3.1. Lentiviral Vectors Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Lentiviral Vectors Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Lentiviral Vectors Market Opportunities
  • 3.4. Lentiviral Vectors Market Future Trends

4. Lentiviral Vectors Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Lentiviral Vectors Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Lentiviral Vectors Market Landscape

  • 6.1. Lentiviral Vectors Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Lentiviral Vectors Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Lentiviral Packaging Systems
    • 7.1.3. Lentiviral Plasmids
    • 7.1.4. Custom Lentivirus Production Services
    • 7.1.5. Ready-to-use Lentivirus
    • 7.1.6. Lentiviral Promoter
    • 7.1.7. Lentiviral Fusion Tags

8. Lentiviral Vectors Market - By Therapeutic Area

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutic Area, 2024 & 2032 (%)
    • 8.1.2. Cancer
    • 8.1.3. Rare Diseases
    • 8.1.4. Infectious Diseases
    • 8.1.5. Neurological Disorders

9. Lentiviral Vectors Market - By Manufacturing Scale

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Manufacturing Scale, 2024 & 2032 (%)
    • 9.1.2. Research Grade
    • 9.1.3. Clinical Grade
    • 9.1.4. Commercial Grade

10. Lentiviral Vectors Market - By Workflow Stage

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Workflow Stage, 2024 & 2032 (%)
    • 10.1.2. Plasmid Construction
    • 10.1.3. Viral Packaging
    • 10.1.4. Purification & Concentration
    • 10.1.5. QC & Analytics
    • 10.1.6. Upstream Processing
    • 10.1.7. Downstream Processing

11. Lentiviral Vectors Market - By Application

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 11.1.2. Gene Therapy
    • 11.1.3. Cell Therapy (e.g., CAR-T)
    • 11.1.4. Vaccine Development
    • 11.1.5. Functional Genomics

12. Lentiviral Vectors Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Lentiviral Vectors Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Lentiviral Vectors Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Lentiviral Vectors Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Lentiviral Vectors Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Lentiviral Vectors Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Lentiviral Vectors Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Aldevron
    • 13.2.2. Bio-Techne
    • 13.2.3. Cell and Gene Therapy Catapult
    • 13.2.4. Charles River Laboratories
    • 13.2.5. Creative Biogene
    • 13.2.6. ExcellGene SA
    • 13.2.7. GeneCopoeia
    • 13.2.8. Merck KGaA
    • 13.2.9. OriGene Technologies
    • 13.2.10. Oxford Biomedica
    • 13.2.11. Sartorius AG
    • 13.2.12. SIRION Biotech
    • 13.2.13. Thermo Fisher Scientific
    • 13.2.14. VectorBuilder
    • 13.2.15. Vigene Biosciences
    • 13.2.16. Wuxi Advanced Therapies
    • 13.2.17. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제